vTv Therapeutics' diabetes drug program hit with clinical hold from FDA
The FDA has handed down a clinical hold to vTv Therapeutics’ lead diabetes program, halting a Phase 3 trial for the oral small molecule candidate …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
